Todos Med Ltd (TOMDF)

[JPetroInc]

Gerald Deranged Realty Syndrome (GDRS) coming right up...



46 more Gerald Deranged Realty Syndrome (GDRS) excerpts right here:

01. playing/sponsoring 'flag-football' is good for shareholders
02. issuing free shares to Wall St. 'has-beens' will attract new investors
03. hiring an 'x-body builder' for PR is a wise decision
04. hiring a 'kiddie influencer' is a sound decision
05. hiring a TaiBo instructor for Todos promotions is going to reverse serial dilution
06. holding photo op's w/ Michael Irvin and NYSE backdrop is good marketing strategy
07. selling 'gummy bears' is the way of the future
08. selling 'no-name' high priced vending machine products is smart
09. has 10-Bil. AS avalanche over-hang on the heads of shareholders is smart
10. thinks serial diluting the shit out of existing shareholders monthly is "financial engineering"
11. issues fake "Word Salad" tweets & PR's repeatedly and non-stop
12. $5-Mil. qtrly. losses on the books and growing
13. desperate crowdfunding offering which won’t raise diddly
14. promotes Israel & Greece EAU’s - but never gets it done
15. keep saying major news is coming - but somehow it never does
16. only issue conference news like JPM and pps drops – mostly on ‘sell the news’ dilution
17. CEO spends all day on Twitter arguing with MD & PhD’s thinking it’s a smart idea
18. investing in failed ParaMoto CV-19 mobile test labs w/ unrecoverable financial losses
19. $50-Mil. vending machine business unable to launch due to "cash flow" shortages
20. crowdfunding financial assistance way behind with missed launch schedules & dates
21. fake spokesperson RS answering MB posts on behalf of company with ulterior motives
22. GC spends all day on Twitter - SH's quote him thinking GC’s statements are the truth
23. deal to sell 3-CL expired Dec 31st with Dr. Arad - still nothing except CEO on Twitter rant
24. Provista employees still not paid, las suit filed – GC didn’t want to meet w/them
25. Monkey Pox test kits only made it to GA grammar school – where’s mass distribution
26. Pres. Biden ends COVID Pandemic on 01/30/23 – Tollovid sales will drop bigley
27. CEO trying desperately to jump on LH-COVID wagon, risky, as in all eggs in 1 basket
28. Lympro? yeah - waiting for ‘German’ polices list of approval before releasing the results
29. Videssa commercialized in 2023? – no Tollovid LH COVID data as promised
30. just how many Tollovid bottles have been sold - what’s total ROI – seems sketchy at best
31. just what’s happening with the purchase of the ultra-expensive Texas lab facility
32. Tollovid sales that have never materialized
33. Monkey Pox testing that’s brought in next to zero revenue
34. Crowdfunding campaign that turned out to be a complete dud
35. 3CL Todos in China - GC said they were sending samples there - really...?
36. has 1:500 SH approved RS in filings just waiting for the right time to ‘drop the bomb’
37. Uplist in 2nd half of 2021 | were focused on creating SH value for our SH's – my arse
38. TOMDF to launch Vedessa clinical study in 2022 to drive sales by 2023 – my arse
39. CEO says NasDaq Uplisting 1st half of 2022, NCL Pharma acquisition of track – my arse
40. “As a result, we have our hospitalized COVID Program on pause" - say good bye to EAU
41. Tollovir is dead - website was down for a week - dilution is through the roof
42. Crowdfunding non-existent, botanical CBD Gummy Bears have gone nowhere
43. Employees being laid off left and right, let alone actually being paid
44. 10-Bil. OS avalanche overhang, 2.3-Bil. AS, 1:500 car wreck RS right around the bend
45. TOMDF is now PINK Delinquent non-reporting - no need to report negative revenue
46. dilution toxic death spiral financing keeping all TOMDF SH’s broke and stuck in this shite

Weekly TA Chart - more GDRS toxic effects on TOMDF SH's:



TOMDF is simply hilarious:



nuff said - proof is in the TOMDF pudding above

MOO dung